ResearcherNational Center for Nanoscience and TechnologyActive in the last 2 years

Junning Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8397-5350; OpenAlex author ID A5005048126. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Integrating network pharmacology and metabolomics to explore the mechanism of Xihuang Pill in exerting anti-tumor immune effects against pancreatic ductal aden… Last author DOI 10.1016/j.jep.2025.120788 ↗
Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer. Last author DOI 10.3389/fphar.2023.1164827 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhiqiao Wang · 1 shared paper, 2026 · strength 0.33
- Paper Integrating network pharmacology and metabolomics to explore the mechanism of Xihuang Pill in exerting anti-tumor immun… DOI 10.1016/j.jep.2025.120788 ↗
Ping Chen · 1 shared paper, 2023 · strength 0.17
- Paper Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer. DOI 10.3389/fphar.2023.1164827 ↗
Yuting Yang · 1 shared paper, 2023 · strength 0.17
- Paper Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer. DOI 10.3389/fphar.2023.1164827 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.